Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf you are already on HRT and your GP has suggested a weight-loss injection, the obvious question is whether Wegovy and HRT can be taken together safely. The short answer is yes, they can be used alongside each other, but the form of HRT you are taking matters, and NHS England guidance suggests it is worth discussing the route of delivery with your prescriber before you start. These are prescription-only medicines, and clinical assessment covers exactly this kind of interaction.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Picture the scenario: you have been managing menopausal symptoms with oral HRT for a couple of years and everything is settled. Now a weight-loss injection has come onto your radar, and you are wondering whether the two will sit happily together. It is a reasonable concern, and one our prescribers hear regularly.
The honest picture from NHS England's guidance on weight-management injections is this: GLP-1 medicines, including semaglutide, slow the rate at which food and other substances move through the gut. For most medicines that is clinically irrelevant. For oral HRT tablets, which depend on reliable absorption from the gut lining, there is a theoretical and practical concern that hormone levels could be less consistent than usual. The formal evidence base is stronger for tirzepatide than for semaglutide, but the clinical principle is the same, and prescribers apply similar caution to Wegovy.
If you are already on Wegovy and taking oral HRT, this does not mean you must stop either medicine. It means the conversation with your doctor or prescriber should include your HRT route, and whether a patch or gel might work better for you going forward. Transdermal preparations bypass the gut entirely, so gastric emptying speed becomes irrelevant. Many women find the switch straightforward.
Transdermal simply means through the skin. HRT delivered as a patch worn on the lower abdomen or a gel rubbed into the thigh or arm releases oestrogen directly into the bloodstream without passing through the digestive system first. That route is unaffected by how quickly your stomach empties, which is exactly why NHS England singles it out as worth considering when starting a GLP-1 medicine.
There is a practical upside too. Many women already prefer patches or gels for other reasons: no daily tablet to remember, steadier hormone levels through the day, and no concerns about stomach upset interfering with absorption on days when nausea from a new weight-loss injection is more noticeable. If you keep your HRT patch in the same drawer as your Wegovy pen (or next to the patch of skin you already use each week) it becomes part of the same routine rather than a second system to manage.
Progestogen component: if your HRT includes a progestogen as a separate oral tablet (rather than a combined patch), the same absorption consideration applies. Discuss with your doctor whether a Mirena coil or a combined preparation might offer more consistent delivery. This is a clinical decision and not one to make unilaterally.
You can find more detail on how semaglutide works and its general side-effect profile on the NHS medicines page for semaglutide, which is updated in line with the current Summary of Product Characteristics.
At a clinical review, your prescriber will want your full medication list. HRT is not a reason to be refused Wegovy, but it does shape the conversation. The prescriber may ask which preparation you are on, whether you are happy to discuss switching to a patch or gel with your GP, and whether your GP is aware you are starting a weight-loss medicine. GP notification is standard practice at our pharmacy, so your own doctor is kept in the loop.
If you are curious about how Wegovy compares with other treatment options, the weight-loss treatment overview explains what is currently licensed in the UK and how the different medicines differ.
One other point worth raising with your prescriber: if you are also using oral contraception, the guidance becomes slightly more specific. For tirzepatide, an additional non-oral contraceptive method is advised during the first four weeks of treatment and after each dose increase. For semaglutide, the evidence base for reduced pill effectiveness is less established, but it is still worth flagging. If this applies to you, the detail is covered in our separate guide to Wegovy and HRT considerations.
If you are already on HRT and thinking about starting Wegovy, the clearest path forward is a consultation where your prescriber can review both together. Trying to piece it together from separate appointments risks things being missed.
Some people ask whether they should pause HRT before starting, or delay starting Wegovy until their HRT is reviewed. In most cases neither pause is necessary, and our we go together Wegovy guide explains how the two treatments can run in parallel while you and your GP discuss HRT route at the next convenient appointment. The main thing is that your prescriber knows about both before approving any new treatment.
For reference on the cost of private Wegovy treatment, the Wegovy price page sets out what a private prescription realistically costs in the UK, including what is and is not typically included at different providers. If you want to explore how the wego together Wegovy programme works before booking, that page covers the support structure in full. If you are ready to discuss your own situation and want to know more before your first injection, our page on whether you can take Saxenda and Wegovy together is worth reading if you are currently on Saxenda or have used it recently. You can also check your eligibility with our prescribing team through a free clinical consultation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.